Meinian Health released its first quarter financial report for 2025 on the evening of April 29. According to the financial report, Meinian Health achieved a total operating income of 1.754 billion yuan in the first quarter of 2025; among which the main revenue combined with AI technology exceeded 54 million yuan, an increase of 71.76% over the same period last year, including revenues such as cardiopulmonary joint screening, AI-MDT report, pharynin, fundus AI, and Naoruijia.

It is understood that Meinian Health has promoted "AI+Health Management" in a multi-dimensional manner at full speed, supporting AI technology and big data, and continuously promoted discipline-driven product solutions, while creating a medical outpatient operation system with weight loss as the core, such as landing in the Shenzhen Weight Loss and Metabolic Center, establishing a "three-teacher co-management" model, namely a professional doctor team, a senior nutritionist team and a certified health management team, and introducing AI health management teachers into the service, providing 24-hour companionship management services and personalized health management suggestions to track the entire process of customer weight management.

At the same time, Meinian Health continues to deeply empower AI technology to help reduce costs scientifically, while improving operational efficiency and optimizing service quality. As of the end of March this year, the intelligent main examination application of "Healthy Xiaomei" has been launched in 109 physical examination centers, reviewing and generating more than 390,000 physical examination reports, and the daily processing capacity of the main examination doctor has been significantly improved.

Meinian Health said that the company adheres to "diversified revenue increase, scientific cost reduction, creating ultimate product strength, and creating ultimate service experience", and takes the physical examination business as the basis of traffic entrance, and uses "specialized, specialized and innovative" products and AI intelligent bodies to further create differentiated competitive advantages, gradually extend post-inspection health care products and services, and continue to focus on the new growth engine of the second curve of health management.

Founder Securities released a research report that Meinian Health is accelerating its upgrade from a physical examination service provider to an AI health management solution platform. "The AI-driven specialized disease early screening product matrix and intelligent health management platform are forming a dual engine for the company's performance growth. With the accelerated release of the value of health data elements, Meinian Health's future platform value has huge imagination space."

[Editor in charge: Wang Yuqi]